Cite
HARVARD Citation
Kinugasa, H. et al. (2016). Low Frequency of Drug-Resistant virus did not Affect the Therapeutic Efficacy in Daclatasvir plus Asunaprevir Therapy in Patients with Chronic HCV Genotype-1 Infection. Antiviral therapy. 21 (1), pp. 37-44. [Online].